Effect of mutations in the nucleocapsid protein (NCp7) upon Pr160(gag-pol) and tRNA(Lys) incorporation into human immunodeficiency virus type 1

J Virol. 1997 Jun;71(6):4378-84. doi: 10.1128/JVI.71.6.4378-4384.1997.

Abstract

COS-7 cells were transfected with DNAs containing mutations in the NCp7 sequences of human immunodeficiency virus. Selective incorporation into the virus of tRNA(Lys) was measured by two-dimensional polyacrylamide gel electrophoresis, and Pr160(gag-pol) incorporation into the virus was detected in Western blots of viral protein. Mutations tested included cysteine and histidine mutations in either of the Cys-His boxes, as well as mutations in the N- and C-terminal flanking regions and in the linker region between the two Cys-His boxes. Of 10 mutations tested, only 2 inhibited tRNA(Lys) incorporation: a P31L mutation in the linker region and a deletion which removed both Cys-His boxes and the linker region (deltaK14-T50). The P31L mutation prevents the incorporation of Pr160(gag-pol) into the virus. Cotransfection of COS cells with both P31L DNA and a plasmid coding only for unprocessed Pr160(gag-pol) resulted in the viral incorporation of Pr160(gag-pol) and the rescue of selective packaging of tRNA(Lys) into the virion. In the deltaK14-T50 mutant, Pr160(gag-pol) is incorporated into the virus. Selective tRNA(Lys) packaging is not rescued by cotransfection with a plasmid coding for Pr160(gag-pol) but is rescued by cotransfection with DNA coding for wild-type Pr55(gag). Since Pr55(gag) does not by itself selectively package tRNA(Lys), the deltaK14-T50 mutation may be affecting tRNA(Lys) binding to a cytoplasmic Pr55(gag)/Pr160(gag-pol) complex.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • COS Cells
  • Capsid / physiology*
  • Capsid Proteins*
  • Chlorocebus aethiops
  • Electrophoresis, Gel, Two-Dimensional
  • Gene Products, gag / metabolism*
  • Gene Products, gag / physiology*
  • HIV-1 / chemistry
  • HIV-1 / growth & development*
  • HIV-1 / ultrastructure
  • Molecular Sequence Data
  • Mutagenesis
  • Nucleocapsid / physiology*
  • Phosphoprotein Phosphatases / metabolism
  • Protein Precursors / metabolism*
  • RNA, Transfer, Lys / metabolism*
  • Structure-Activity Relationship
  • Viral Proteins*
  • Virion / ultrastructure*
  • Virus Replication*
  • gag Gene Products, Human Immunodeficiency Virus
  • pol Gene Products, Human Immunodeficiency Virus

Substances

  • Capsid Proteins
  • Gene Products, gag
  • NCP7 protein, Human immunodeficiency virus 1
  • Protein Precursors
  • RNA, Transfer, Lys
  • Viral Proteins
  • gag Gene Products, Human Immunodeficiency Virus
  • pol Gene Products, Human Immunodeficiency Virus
  • pr160 gag-pol precursor protein, Human immunodeficiency virus 1
  • Phosphoprotein Phosphatases